Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
BMJ Open. 2024 Feb 2;14(2):e078473. doi: 10.1136/bmjopen-2023-078473.
Forcibly displaced people (FDP) have a high risk of developing mental disorders such as post-traumatic stress (PTS) disorder. Providing adequate mental healthcare for FDP is crucial but despite overall efficacy of many existing interventions, a large proportion of FDP does not benefit from treatment, highlighting the necessity of further investigating factors contributing to individual differences in treatment outcome. Yet, the few studies that have explored moderators of treatment effects are often insufficiently powered. Therefore, the present Individual Patient Data meta-analysis (IPD-MA) will investigate treatment effects and their moderators-variables related to beneficiaries, providers, intervention and study characteristics in relation to PTS outcomes.
A systematic literature search will be conducted from database inception in the databases PsycINFO, Cochrane, Embase, PTSDpubs and Web of Science. Only studies published in English, German, French, Spanish, Portuguese, and Dutch will be considered. Retrieved records will be screened for eligibility. Randomised controlled trials on adult FDP receiving psychological and psychosocial interventions aimed at alleviating symptoms such as PTS compared with a control condition without intervention will be included in this IPD-MA. Subsequently, authors of eligible studies will be contacted to request individual patient data (IPD). All datasets obtained will be synthesised into one large dataset which will be analysed using a one-stage approach by conducting mixed-effects linear regression models (ie, primary analysis). Additionally, aggregate data meta-analyes will be run using a two-stage approach by conducting multivariate regression models including all IPD (transformed) and available meta-data from study reports (ie, secondary analysis). PTS will serve as primary outcome measure, while mental health outcomes other than PTS, attendance, attrition, treatment non-response and adverse outcomes will be examined as secondary outcomes.
This IPD-MA does not require ethical approval. The results will be published in international peer-reviewed journals.
CRD42022299510.
被迫流离失所者(FDP)患创伤后应激(PTS)障碍等精神障碍的风险很高。为 FDP 提供足够的精神保健至关重要,但尽管许多现有干预措施总体上有效,但很大一部分 FDP 并未从中受益,这凸显了进一步研究导致治疗结果个体差异的因素的必要性。然而,少数探索治疗效果调节剂的研究通常没有足够的效力。因此,本项个体患者数据荟萃分析(IPD-MA)将调查治疗效果及其调节剂——与 PTS 结果相关的受益人、提供者、干预措施和研究特征的变量。
将从数据库成立开始在 PsycINFO、Cochrane、Embase、PTSDpubs 和 Web of Science 数据库中进行系统文献检索。仅考虑发表英文、德文、法文、西班牙文、葡萄牙文和荷兰文的研究。检索到的记录将进行筛选以确定其是否符合资格。这项 IPD-MA 将纳入成年 FDP 接受旨在缓解 PTS 等症状的心理和心理社会干预的随机对照试验,与无干预的对照条件相比。随后,将联系合格研究的作者以请求获取个体患者数据(IPD)。将所有获得的数据集综合到一个大型数据集中,该数据集将通过使用混合效应线性回归模型(即主要分析)进行分析。此外,还将通过使用包括所有 IPD(转换)和研究报告中可用元数据的多变量回归模型(即二级分析)进行汇总数据荟萃分析。PTS 将作为主要结局测量指标,而 PTS 以外的心理健康结局、出勤率、流失率、治疗无反应和不良结局将作为次要结局进行检查。
这项 IPD-MA 不需要伦理批准。研究结果将发表在国际同行评议期刊上。
PROSPERO 注册号:CRD42022299510。